ABAChem is a fast-growing company providing custom manufacturing services to the pharmaceutical, biotechnological and agrochemical industries. ABAChem offers a broad spectrum of manufacturing services for the production of fine chemicals, advanced intermediates, and active pharmaceutical ingredients. We have successfully collaborated and partnered with major pharmaceutical and chemical companies globally.ABAChem has become a reliable development and manufacturing service provider to meet clients' outsourcing needs by offering cost-effective and time-efficient services and products.
Accela ChemBio was founded in 2007, as a global leading provider in custom synthesis, process optimization and scale-up production, owned 3 R&D centers, 1 manufacture base, as well as a subsidiary in USA. Our mission is to provide high-quality, innovative products and technical services to our valuable customers. Accela's core business focus in Process R&D and Manufacturing of specialty chemicals and pharmaceutical intermediates.
AGC Chemicals belongs to AGC Inc., a world-leading producer of glass, chemicals, electronic materials and ceramics. AGC Chemicals is a fluorine specialist, active in CDMO custom chemical synthesis & the production and development of APIs & intermediates, all in compliance with GMP. Continuous improvement is key within AGC.
Agno Pharma is a global pharmaceutical contract research and manufacturing organization (CRO & CMO). Agno Pharma engages in the research, development, manufacturing, sourcing, marketing and distribution of chemically and biologically derived pharmaceutical intermediates, APIs, nutraceuticals, and fine chemicals. Agno Pharma is a fully integrated company with in-house business development, R&D, manufacturing and regulatory compliance capabilities. Agno Pharma is your strategic CRO & CMO for your drug discovery, development, and commercialization.
Ajinomoto will have two businesses represented at CPhI: the Amino Science division and Ajinomoto Bio-Pharma Services. Ajinomoto Amino Sciences develops and manufactures high quality amino acids for the bio-pharmaceutical industry. The amino acids are produced under cGMP conditions with non-animal materials, and are unsurpassed in quality and purity. Ajinomoto Bio-Pharma Services is comprised of the recently unified Ajinomoto Althea and OmniChem organizations. Ajinomoto Bio-Pharma Services is a global and fully integrated CDMO for small and large molecules, providing comprehensive process development services, cGMP manufacturing and aseptic fill finish services, including ADCs/cytotoxics and oligonuceotides.
AAI Pharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form Alcami, a world class supplier of comprehensive pharmaceutical development and manufacturing services. With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services.
AmbioPharm Inc (API) is a full-service peptide manufacturing company headquartered at our cGMP peptide manufacturing facility in North Augusta, S.C. In our cGMP manufacturing facility in Shanghai, China, we manufacture peptides at very large scales, provide pilot manufacturing and process development, and manufacture raw materials, building blocks, and custom peptides. Our two cGMP facilities are capable of handling any manufacturing scale to produce bulk peptides to custom specifications using a wide-range of skill sets in solid and solution-phase chemistry. In addition to manufacturing peptides, we also perform organic conjugations of peptides to proteins, toxoids, antifungals, KLH, and PEG.
Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations. Our experience: - 14 years of GMP manufacturing of CGTs and biological drugs; - 61 years of Contract Manufacturing within our Group (Holding F.I.S.) Our business: - Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells) - High-Quality Plasmid for Viral Vector Manufacturing. - Project 2020: to address up to commercial scale needs for CGTs. - Big Data Analysis
Anthem Biosciences is a Bangalore based Contract Research and Innovation Service Provider (CRISP), located in an Industrial Park in Bangalore with a built-up capacity to house over 500 researchers. Currently, the company employs over 350 people with plenty of room for adding extra capacity.
The people at Anthem Biosciences bring years of relevant experience to the company. A team of experienced Chemists, Biologists, Engineers and Business people own the responsibility of transparent and ethical dealing with customers.
Our CRISP model – Anthem offers a whole gamut of services dedicated to enabling and sustaining global research efforts in the discovery of new compounds by pharmaceutical, biotechnology, specialty chemicals, agriculture chemicals and material science companies. This is done by leveraging the company's core competencies in organic synthesis, process development, analytical chemistry, discovery biology and regulatory compliance.
With its best in class infrastructure Anthem Biosciences can do GMP synthesis ranging from milligram to kilogram, multi-kilogram to multiple tonne scale. Apart from modern well equipped labs, the company has a cGMP kilo lab and a versatile GMP pilot plant.
In Discovery Research, Anthem provides pharmaceutical clients services from generation of hits, transforming hits to leads and optimization of leads to developable drug candidates against known or client's targets. The company has recently commissioned new laboratory space, more than doubling its lab capacity. A new GLP compliant in-vivo facility, new ADMET labs and a pilot fermentation lab have been added.
Anthem Biosciences works with clients on various business modules like FTE (Full Time Equivalent) or FFS ( Fee for Service) or a combination of the above, depending on the complexity of the task and the need of the client. The company is flexible in its approach in evolving sensible and efficient models that suit each client.
In the ever crowding space of CROs, Anthem Biosciences distinguishes itself as a top tier organization, with a highly skilled team, quality services and a guarantee of on-time performance.
Apollo Scientific offers a huge range of organic intermediates (currently over 75,000). In our own UK laboratories we manufacture fluorochemicals and key heterocyclic building blocks in quantities from just a few grams to over 50kg. Many of these compounds are novel and we are regularly supplying interesting new molecules to the pharmaceutical industry from an initial small requirement, through kilo-lab and beyond. Apollo also undertakes custom synthesis work, and has agreements in place with approved third-party toll converters. Therefore if required, quantities over 100Kg of our own manufactured intermediates can be provided using technology transfer of Apollo's procedures.
Leading fine and specialty chemicals group, French based, Axyntis with its 350 employees offers a deep rooted technical experience. The fine chemicals division (380 m3 under cGMP), is split into four plants (all AFSSAPS and one FDA approved): Orgapharm is designed for key advanced intermediates and exclusive APIs; Centipharm for key intermediates and generic APIs; AllChem for key intermediates -electronic, agro; Synthexim for key intermediates for pharma. Orgapharm and Centipharm bring in addition R&D and Pilot capabilities. With a wide range of key technologies, Axyntis is a specialist for various products such as indoles, quinolines, resolving agents, quinuclidines, fluoro aromarics
- Liquid phase peptide synthesis (LPPS)
- Solid phase peptide synthesis
- Peptide purification up to 300 mm DAC columns
- Bulk tray lyophilization
- Process Development
- Analytical Development and Validation
- Process Scale Up
- Reference Standard
- GMP Manufacturing
- Stability Studies
- Regulatory Support
CARBOGEN AMCIS has a 25 year history in contract chemical process R&D including the supply of highly active (0.1 ug/m3) pharmaceutical ingredients (APIs), both for clinical trials and commercial use. Our new High Potency facility, on the site of our parent company in India, includes vessels up to 2,500L complementing the existing facilities in Switzerland. We provide Innovative Chemistry Solutions to address complex chemistry issues through our state-of the art facilities, procedures and most importantly our staff. Specialist areas include chromatography, analytics, micro-reactor technology and dedicated High Potency services. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals, Limited.
Carbosynth are the global supplier of carbohydrates, nucleosides and fine chemicals to the pharmaceutical and bio-tech communities. Our production and laboratories are established in UK, USA and China. Custom synthesis is a growing part of our business in carbohydrates and nucleosides along with our growing capability in fine chemicals.
Carbosynth have diverse and broad experience in chemistries that range from small laboratory scale multi-step synthesis to large scale multi-tonnage manufacture and are able to draw upon a wide range of experience in chemistries and processes, especially in the fields of carbohydrates. This ranges from carbohydrate synthesis to extraction, separation and purification of natural polysaccharides, including monosaccharide building blocks, sugar phosphates, sugars nucleotides, enzyme substrates, oligosaccharides, polysaccharides and glycoconjugates. Carbosynth also offers a range of niche fine chemicals that include versatile building blocks or products with specialist applications ranging from biochemical reagents, natural antioxidants, coupling agents, to activators in peptide and oligonucleotide synthesis.
Central Glass Group is specialized in all about fluorine chemistry. We can do various reactions with a great quality management and waste treatment system. We supply fluorine chemicals with gram scale to ton-scale, cGMP if necessary. We are very confident in our innovative reactions and we do hope that our competence is surely of your help. Our global coverage (Japan/US/Europe) can satisfy you with quick response and good customer care. If you need fluoro compounds, please contact us!!
Central Glass Germany is dedicated to process development, upscaling and production of active ingredients and intermediates for the pharmaceutical and cosmetics industry. It operates a FDA
and EU inspected facility in Halle-Kuensebeck. An experienced and highly skilled team of organic chemists and support functions, such as analytical specialists and QA/QC team, ensure success and high quality of our projects.
Our service offering includes:
- Process Development and upscaling from grams to tons.
- Custom synthesis for pre-clinical studies, Phase I-III trials and launch.
- cGMP production of commercial APIs and Intermediates.
- In-process and finished API analytical methods development.
- Validation of manufacturing processes and analytical methods.
- ICH stability studies for registration.
- Comprehensive support for CMC file preparation.
We are mainly engaged in process development of fine chemicals such as Agrochemicals, pharmaceutical intermediates, etc. Dalian Join King has established world class proprietary technology platforms based on core technologies such as heterocycles, chiral chemistry and semi-synthesis, who has been in cooperation with many top 500 companies such as DOW, DuPont, Bayer, FMC, Ella Lilly, DSM and so on, established strategic partnerships and provided them with CRO, CMO services and custom manufacturing service.
Delmar, a Holding F.I.S. company, specializes in custom cGMP synthesis of APIs and advanced intermediates. Delmar has well-equipped Process R&D and Analytical R&D laboratories, a cGMP kilo lab, a cGMP pilot plant and multi-ton cGMP manufacturing. Delmar offers a full range of development and manufacturing services including cGMP custom synthesis from gram to multi-ton quantities, analytical method development and validation, process development and validation, ICH stability studies and complete regulatory documentation including the preparation of CMC sections and Drug Master Files in CTD format.
Digital Specialty Chemicals (DSC), based in Toronto, Canada, develops
and manufactures high-quality organophosphorus and organometallic chemicals for
the pharmaceutical, specialty chemical and electronic-materials markets. DSC's product
line includes phosphine ligands (including Buchwalds) for homogeneous
catalysis, phosphorylating reagents and challenging organometallics, available
from kilogram to metric ton quantities. DSC offers custom manufacturing
services, with focus on air, moisture and heat sensitives. Through practicing
‘The Chemistry of Excellence', every employee at DSC partners to deliver, new
thoughts, breakthroughs and new solutions to meet development milestones and
produce materials at the highest possible purity on a consistent, repeatable
basis. WE MAKE CHEMISTRY MATTER
"Dishman Group" is not a separate legal entity but nomenclature used in generality for Dishman Pharmaceuticals and Chemicals Limited, the flagship Company, and its Indian and foreign subsidiaries, joint ventures and associate companies across the globe. All these entities are individual and separate by the law.
Dishman is a global, dynamic group of companies offering a continuum of services to the pharmaceutical industry. We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services.
The Dishman Group continually invests in the pharmaceutical industry, ensuring Dishman's businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future.
Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. Our business is successful only when our customers are successful.
Download our corporate brochure here.
Dishman is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services.
The products and services offered span customers' needs from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.
Dishman has a relationship driven business model that improves its customers businesses by providing a range of solutions at locations in Europe, China and India.
Esteve Química has 50 years' experience developing, manufacturing and marketing oral and injectable-non-sterile grade API's (generic and NCE's for third-parties) for regulated markets. Our services include process and analytical development, scale-up, analytical transfer, validation, process optimization and commercial manufacturing, along with any required technical services. We offer particle engineering posibilites (micronization, spray-drying ...). We are regularly inspected by major Health Authorities (USA, Europe, Japan ...). Our cGMP's multipurpose plants (two in Spain (EQ Esteve), one in Mexico (Sintenovo) and one in China (EHP) have a total capacity in exess of 800m3 and clean room areas for the last steps of manufacturing.
Esteve Huayi Pharmaceutical Co Ltd (EHP) is a joint venture between the Spanish Esteve Group and the Chinese Huadong Medicine Group.
Esteve Huayi Pharmaceutical Co Ltd is an industrial platform in China from which to supply the most demanding APIs markets (USA, EU, Japan) as well as the growing Chinese domestic market. It specializes in the development, manufacturing and commercialization of APIs and high-value added advanced intermediates as well as offering good opportunities for custom synthesis and toll manufacture projects using its state-of-the-art facilities with a wide range from cGMP-compliance kilo lab to commercial production, expertise in a variety of reaction types and a highly-qualified professional team
Eurofins Alphora provides API technology development services for complex niche small molecules, covering pre-clinical to Phase III and commercial manufacturing. Alphora operates FDA-approved facilities totalling 51,000+ ft² including cGMP Kilo Laboratories and cGMP Plant operations, R&D and Analytical laboratories, QC/QA, as well as a separate high potency/cytotoxic facility.
Chemical Industries Co Ltd is a leading manufacturer of Active Pharmaceutical
Ingredients, Drug Products, Excipients and Natural Astaxanthin. Our specialized
contract manufacturing offers API synthesis, solid dispersion with our spray
drying technology, etc. Additionally, we offer unique excipients for oral
dosage forms, such as Neusilin, Fujicalin. and F-MELT.
Zhejiang Huayi Pharmaceutical Co Ltd (ZHP) is a company specialized in developing, manufacturing and commercialization of APIs and advanced pharmaceutical intermediates as well as custom manufacture business. ZHP plant has been US FDA and EU GMP approved, as well as ISO14001 and OHSAS 18000 certified. A 350 CBM of reactor capacity and our capability in a variety of reaction types including low temperature, Chiral synthesis, Hydrogenation are offering a wide range of business collaboration.
Founded in 1994, Hebei Yanuo Chemical Industry Co Ltd is an export-oriented enterprise specialized in the research, development, production and sales of fine chemicals. Our products fall into two general categories which are organic sulfur compound and pyridine derivate. In addition, YANUO has strong R&D capability, rich operating experience and strict HSE and quality management systems, of which our quality system has been accredited by ISO-9001. Our products have entered European, American and Asian markets. Our quality products and satisfactory services enable us to establish and maintain extensive and sound cooperative relations with clients from home and abroad.
Hindustan Platinum, established in 1961 is India's leading manufacturer and refiners of precious metal products with wide and diverse industrial applications. Over the years, HP has established a large customer base in India, USA, Europe, UK and Asia. With the world as our market, HP is truly global player in the precious metal products, processes and services Industry.
Reliable Partner in synthesis of API : PGM Heterogeneous powder catalysts – Platinum Palladium Rhodium, Ruthenium impregnated on carriers activated carbon, barium sulphate, calcium carbonate, alumina.
Unsupported Catalysts - Platinum/Palladium/Rhodium Oxide, PGM Salts and homogenous catalysts for chiral and non-chiral synthesis.
F.I.S., belonging to the privately owned group “Holding F.I.S.”, is a leading Chemical-Pharmaceutical Manufacturer with more than 2000m3 of production capacity, committed to develop-produce-deliver High-Quality substances for the Pharmaceutical Industry.
Main Offerings: New Chemical Entities (NCEs) Custom Synthesis & Contract Manufacturing (CMO), Generics APIs, Key Intermediates and Building Blocks.
Hovione is an international company with over 58 years of experience as a Contract Development and Manufacturing Organization (CDMO) and is currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. Hovione offers a full range of development services and manufacturing capacity in particle engineering (Spray Drying, Spray Congealing, Hot Melt Extrusion, Jet Milling, Nanoparticles and Wet Polishing) to provide optimal solutions for your drug product with the right scale and flexibility. For generic pharmaceutical customers the company offers niche API products. Hovione also provides proprietary product development and licensing opportunities for drug products. In the inhalation area, Hovione is the only independent company offering a complete range of services. Please visit www.hovione.com
Hunan Er-Kang Pharmaceutical Co Ltd, founded in October 2003, is specialized in the R&D, production, and sale of pharmaceutical products, boasting China's largest pharmaceutical excipient manufacturer with full range of products and also one of the few enterprises who has obtained Drug Approval Number for sulbenicillin sodium, a new type penicillin. Er-Kang's products are now sold to over 4000 pharmaceutical enterprises worldwide.
Er-Kang is a China leader in researching and delivering 100% vegetarian,high-quality and reliable starch capsules (StarchCaps ), starch for softgel shells (StarhGel ), pharmaceutical excipients and APIs to pharmaceutical, nutrition and cosmetics companies around the world.
IBI Istituto Biochimico Italiano G. Lorenzini S.p.A. is an independent Italian research-based pharmaceutical company pioneer since 1918 in the development, production and marketing of medicines worldwide. Following our mission of “creating to contribute”, we have used innovative technology to develop a portfolio of products to improve the health of patients. IBI is present has an established leadership in penicillin market and capability of aseptic filling for injectable drug products aimed for different therapeutic areas. IBI's high quality standards is internationally recognized by the most demanding health authorities : AIFA, US FDA, EDQM, TGA and PMDA. R&D is one of the strengths of the Istituto Biochimico Italiano. Thanks to the fact that many manufacturing processes have been developed entirely in house; from the semi synthesis of active substances (ß-lactam) to the development of the formulations, the company has obtained numerous patents. Investment in resources and in innovative equipment enables us to continuously improve production and analytical processes.
The company IGS was formed in 1976 as the result of a MBO from Dynamit Nobel AG. In two manufacturing plants IGS currently produces over 2000 of its own formulations including products for human and veterinarian medicine. The company is certified according to ISO 9001, 14001, 13485 and VO (EEC) 1836/93. As a neutral contract aerosol filler IGS develops marketable formulations, improves existing recipes and prepares the entire galenic dossier for the manufacture and filling of aerosol-compatible preparations with or without propellant. The product range includes all pharmaceutical aerosols, filling of asthmatic dosage aerosols, notably Budesonid and Salbutamol MDIs, DPIs.
IHT Group consists of IHT (Beijing), IHT(Tianjin) and IHT (Jiangsu), and is the leading manufacturer of photoinitiators, pharmaceutical intermediates and fine chemicals manufacturer with the ability of successively technology innovation and scale-up production.
It is the leading enterprise in the UV curing industry of China and the main supplier of middle and high-end photoinitiators for global UV curing market with partners all over the world.
By applying its unique combination of bio-transformations and organic synthesis, Kaneka is manufacturing advanced intermediates for 40 years for the pharmaceutical industry. Kaneka is a research driven manufacturer supplying valuable chiral synthons produced by innovative and cost-effective processes. Kaneka's intensive R&D activities make it possible to support its customers worldwide from laboratory over pilot to full GMP manufacturing scale.Kaneka is the pioneer in natural CoQ10 (Ubidecarenone) and is the only manufacturer offering also the biologically-active form (Ubiquinol).Kaneka Eurogentec offers contract GMP biologics manufacturing (proteins, plasmids, and conjugates, through microbial fermentation via its FDA-approved production site in Belgium.
As a manufacturer and a supplier, Kingchem provides supply-chain assurance to the Pharmaceutical, Agrochemical, Electronic, Fine and Specialty Chemical industries through our sharp focus on customer service, our wholly-owned R&D and manufacturing facilities, and our robust network of pre-qualified Chinese manufacturing partners. For basic starting materials, advanced intermediates, regulatory starting materials, or custom APIs meeting your specifications, let Kingchem tailor a solution to your needs with our competitively-positioned contract research, process development, custom manufacturing, fermentation and chemical synthesis. For kilograms or multi-ton range, leverage Eastern value and Western management by letting Kingchem be your China sourcing solution.
Koei Chemical Co Ltd specialized in manufacturing high-quality
pyridine derivatives, amines, and nitrogen-based downstream compounds, just expanded
its capacity by constructing a new multi-purpose plant completed in April 2017
and started production in June 2017, to meet customer's potential demand for
pharmaceuticals, agrochemicals, and various other applications.
Lianhe Chemical Technology Co Ltd, established in 1985 as private company and listed in Shenzhen Stock Exchange in 2008, is an ISO9001, ISO14001 &OHSAS 18001, GMP certified manufacturer of API, intermediates for Pharmaceuticals, Pesticides, electronic & photographic chemicals, as well as provider of contract/toll manufacturing services with over ten years experience. Now our company operates from two sites, with one in Zhejiang Province and the other in Jiangsu province. Our mission is to make our partners more competitive and we always keep regular communications with our customer, and attach much importance to IP protection, EHS. Our Key technologies including Ammoxidation,Halogenation Hydrogenation, cyclization, Grignard reaction.
Lundbeck Pharmaceuticals Italy SpA is an APIs manufacturer with 80 years of experience, part of H. Lundbeck A/s. group. FDA inspected and approved since 1972, inspected and approved by EMEA and Japanese PMDA, it manufactures products and provides services to key players in the fields of Generics, and Brand Pharmaceuticals. With 120 m3 of capacity, large Thin Film Distillation units, Solid Phase Extraction on large scale, expertise on crystallization and solid mixtures, Kilo Lab, Pilot Plant and a Finishing Department, all capable of operating in ISO 7, focuses on production of specialty APIs, and those requiring high levels of containment.
Meksmar was founded in 1996 and has been specialized in producing lozenges, herbal pastilles & cough drops. Meksmar is the leading producer for pharma quality lozenges and has 16 registered brands and has been contract manufacturing more than 20 brands for both domestic & international pharmaceutical companies. Apart from domestic sales, Meksmar exports its product range to 21 countries in 4 continents. Meksmar provide a range of pastilles and lozenges which offers unique benefits for sore throat, cold, hoarseness and also offers unique formulations with API & natural extracts to let the body increase it's resistance. Production is held on under the standards of ISO 22000:2005 and ISO 9001:2008 and following GMP.
MINAKEM is specialized in custom manufacturing of complex, advanced intermediates and APIs and HAPIs under strict cGMP conditions for the pharmaceutical industry. All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state-of-the-art analytical services including solid form and QbD laboratories. The R&D team is dedicated to process development, organic synthesis and analysis, and works under a secrecy agreement. The total capacity of its multi-purpose plant (FDA inspected) is 290m3. Minakem performs reactions under extreme temperature (from -100 to +300°C) and has dedicated workshops for hydrogenation, cyanidation, bromination. MINAKEM, with offices and production sites in Louvain-la-Neuve (BE), Dunkirk (FR) and Beuvry-la-Forêt (FR) is an affiliate of the MINAFIN Group and as such has access to all technologies, resources, and capabilities to respond to its client's needs, especially with MINASCENT technologies (Leuna, Germany), and PENNAKEM (Memphis, TN, USA).
MinAscent Technologies is the Germany-based chemical unit of the Minafin group, operating from Leuna chemical park. Its 100 m³ total reactor capacity (10 to 10000 liter) supplies multiple organic synthesis industries including Pharmaceuticals, Food & Feed additives, Agrochemicals, Flavours & Fragrances, Polymer additives, Cosmetics. Site is GMP- and HACCP-capable, and FDA-inspected for several productions. It operates a variety of special technologies including thermal dehydrations, batch and fixed-bed hydrogenation including hastelloy autoclave, sulfur, selenium, allene, acetylene, and hydrazine chemistry on custom manufacturing basis, as well as several regular products originating from Diterbutyldicarbonate (DiBoc) home production.
Chemlin Nanjing Chemical Industrial Co Ltd was established in December 1999, the business scope includes the sale of general trade, custom synthesis, contract processing. Our business products include bulk cargo, solvent business, specialty chemicals, fine chemical intermediates, agricultural products, pharmaceutical products, natural products, and biochemical products and many other businesses.
Finetech offers increased capacity and profound know-how for chemical development. Its experience and proven track record gives confidence that projects will be cost-efficient, expertly performed and delivered on time. With its services, products and technologies Finetech provides integrated solutions to the pharmaceutical and biopharmaceutical industry worldwide. Its technology portfolio comprises low temperature,high pressure reactions and continuous processing, Finetech chemical runs its technologies on dedicated and multipurpose equipments on all scales under a quality system based on the process approach of ISO 9001:2008, which includes GMP according to ICH Q7 as well as safety, health and environmental (SHE) protection. A full service offering to speed up time from small-scale to commercial production is our characteristic.
With a total 260 people, 100 highlytrained researchers' efforts are optimized to allow for flexible and fast responses to customers needs. The streamlined decision process, the ability to ramp up production quickly, the state-of-the-art plants and equipment operated by highly-trained employees allow us to achieve our customers' ambitious targets.
With flawless plant and strict management process, We offers full-scale chemical GMP&non-GMP production . Finetech Chemical's one-site strategy allows reduced decision and communication pathways, thus ensuring rapid and efficient project development as well as clear and transparent communication with customers.
Nantong Sane Biological Co Ltd was founded in 2000. It is a high-tech enterprise engaged in researching, developing and marketing nucleotide pharmaceutical intermediates and relevant fine chemicals. Based on international and domestic markets and outstanding technological progress, insisting on the ideas of sustainable development and green production, unique advantage of chemical industrial park, the company is striving to establish R&D and production base of nucleic acid, pharmaceutical APIS focused on nucleic acid products and pharmaceutical AIPs. We'll offer new and existing customers more professional and excellent products and services.
Navin Fluorine International Ltd (NFIL) is one of the largest and the most respected Indian manufacturers of speciality fluorochemicals. It belongs to the Arvind Mafatlal Group – one of India's oldest industrial houses. Established in 1967, NFIL operates one of the largest integrated fluorochemicals complexes in India with manufacturing locations at Surat and Dahej in Western India and Dewas in Central India. Our R&D centre named as Navin Research Innovation Center (NRIC) is located at Surat, India.
NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.
NCK offers all relevant services for fulfilling regulatory requirements when applying for an IND / IMPD. NCK is built on the foundation of Synthetic Organic Chemistry, and we have seen and have been involved in most of the latest innovative chemistry.
Novasep provides an extensive range of contract development & manufacturing (CDMO) services to the pharmaceutical industry for both Small Molecule APIs and Biopharmaceuticals. With 1,300 employees, Novasep is established in Europe, Asia and North America and is constantly expanding its presence to better serve its customers. We aim to be a highly respected, top tier service provider through the passion of our people and the excellence of our processes. Our CDMO services include:
- APIs and HPAPIs
- cGMP intermediates and starting materials
- Viral vectors (AAV, ADV, Lentiviral vectors…)
- Monoclonal antibodies and other recombinant proteins
- Antibody drug conjugates (ADCs)
- Fill & Finish for biologics
- Senrise-IV: a new commercial manufacturing facility for viral vectors, in Novasep Seneffe, Belgium
- Senefill: a new commercial facility for aseptic Fill&Finish operations in Novasep Seneffe, Belgium (filling of mAbs, viral vectors, plasmids and other biologics)
- mAbulous: a new clinical manufacturing facility for mAbs and recombinant proteins, in Novasep Pompey, France, addressing both process transfer and cGMP production
ORGANICA® Feinchemie GmbH Wolfen is a company producing
chemicals which are renowned for their functionality and high quality. Apart from fine chemicals for various branches of the
industry, ORGANICA® is able to
provide functional dyes as well as pharmaceutical intermediates – tailored to
their customers' specific requirements.
As an expert in safety-critical operations and hazardous reactions, high-pressure reactions and reagents such as CS2, H2S, fumic sulfuric acid as well as NaN3 are included in ORGANICA®'s daily business. The facilities are located in Bitterfeld-Wolfen, which is part of the Middle German Chemical Triangle. They comprise a fully equipped R&D department and quality assurance laboratories. ORGANICA® operates a modern pilot plant and a multi-purpose plant (ISO 9001, ISO 50001) as well as a cGMP operated Kilo-Lab (clean room ISO 75; class 10 000). The total reactor capacity adds up to 97 m³. Due to ORGANICA®'s various reactor types and sizes they are able to offer multistep syntheses ranging from grams to multi-tons (up to 100 MT per product and year).
The long-term experience enables ORGANICA® to quickly and flexibly transfer novel projects from the R&D department to its production facilities. Currently, ORGANICA® manufactures more than 320 products based on optimized synthetic procedures.
ORGANICA® Feinchemie GmbH Wolfen - Your Reliable Partner for Custom Syntheses
Osmopharm SA is a Swiss pharmaceutical contract manufacturer specialized in the development and production of modified release solid oral form drugs. Osmopharm SA is GMP certified by the Swiss health authority Swissmedic, certificate with European validity thanks to the mutual recognition agreement between EU and Switzerland in accordance with quality and good practices defined by PIC/S (Pharmaceutical Inspection Convention/Co-Operation Scheme). With more than 150 formulations developed, the production capacity reaches 36 tons/month of nonsterile products in solid multi-dose form (controlled release granules) and unit dose form (controlled release tablets and capsules). Products: pellets, capsules, tablets in bulk and final packaging.
SIA "P&M-Invest" Ltd. is the first private chemical company in Russia. It was organized in the period of "Perestroika" in USSR, in 1987 and for more than 25 years our company specialized in the field of organo-fluorine chemistry. We manufacture the products in small quantities in our lab. and for commercial quantities on the plant near Moscow. SIA "P&M-Invest" Ltd. is the supplier of unique organo-fluorine products with the special application. We synthesize the product that are not described in Scientific literature, carry out scientific researches under the development of methods of synthesis and create our own technologies for our internal production (see in details "directions").
Penn A Kem is a high-tech Specialty Chemical Company with over 60 years of Specialty and Fine Chemicals development and manufacturing experience; a wide range of expertise in vapor phase and liquid phase catalytic hydrogenation processing; a modern, efficient manufacturing facility in Memphis, Tennessee, with over $75MM of capital investment in the last seven (7) years; and a strong and experienced staff of Research, Technical Support, and Quality Control experts on hand to support customer needs.
Our product portfolio based on Furfural and Furan made from renewable resources that supports a wide range of Specialty Applications.
We also offer full scale R&D and Pilot Plant process/product development services with emphasis on catalytic hydrogenation and semi-works and production scale custom manufacturing services .
PHF SA is a Swiss company part of the Holding F.I.S., active globally in the pharmaceutical, nutritional and medical device businesses.
As a real “projects engine”, with strong expertise and skills, PHF SA can support valuable partners in their own success.
Thanks to the expertise and skills of its multi-function team, PHF can globally manage any development project, offering innovative, quick and competitive solutions.
PHT International Inc is a full-service fine and specialty chemical company, providing manufacturing capabilities, research and development, sample generation and packaging, procurement, logistics and regulatory compliance. PHT International serves four main sectors of the chemical industry. These include the following: Agricultural: Intermediates and actives Pharmaceutical: Intermediates, APIs and high purity solvents Food/Beverage: Flavors, fragrances, natural extractions, additives Polymer/Industrial: Monomers and commodities
Porton is a leading China-based Contract Manufacturing services provider, serving the global pharmaceutical industry with seamless custom and contract chemical development and manufacturing services from preclinical development to commercial supply.